全文获取类型
| 收费全文 | 21516篇 |
| 免费 | 2648篇 |
| 国内免费 | 497篇 |
专业分类
| 耳鼻咽喉 | 115篇 |
| 儿科学 | 313篇 |
| 妇产科学 | 202篇 |
| 基础医学 | 1300篇 |
| 口腔科学 | 404篇 |
| 临床医学 | 3437篇 |
| 内科学 | 2694篇 |
| 皮肤病学 | 436篇 |
| 神经病学 | 1133篇 |
| 特种医学 | 884篇 |
| 外国民族医学 | 10篇 |
| 外科学 | 1467篇 |
| 综合类 | 3223篇 |
| 预防医学 | 2079篇 |
| 眼科学 | 368篇 |
| 药学 | 3352篇 |
| 90篇 | |
| 中国医学 | 1753篇 |
| 肿瘤学 | 1401篇 |
出版年
| 2024年 | 131篇 |
| 2023年 | 575篇 |
| 2022年 | 971篇 |
| 2021年 | 1437篇 |
| 2020年 | 1485篇 |
| 2019年 | 1045篇 |
| 2018年 | 936篇 |
| 2017年 | 1155篇 |
| 2016年 | 1123篇 |
| 2015年 | 981篇 |
| 2014年 | 2032篇 |
| 2013年 | 1954篇 |
| 2012年 | 1441篇 |
| 2011年 | 1301篇 |
| 2010年 | 1072篇 |
| 2009年 | 892篇 |
| 2008年 | 726篇 |
| 2007年 | 741篇 |
| 2006年 | 667篇 |
| 2005年 | 607篇 |
| 2004年 | 470篇 |
| 2003年 | 429篇 |
| 2002年 | 340篇 |
| 2001年 | 336篇 |
| 2000年 | 248篇 |
| 1999年 | 166篇 |
| 1998年 | 190篇 |
| 1997年 | 150篇 |
| 1996年 | 114篇 |
| 1995年 | 128篇 |
| 1994年 | 96篇 |
| 1993年 | 80篇 |
| 1992年 | 85篇 |
| 1991年 | 57篇 |
| 1990年 | 64篇 |
| 1989年 | 51篇 |
| 1988年 | 64篇 |
| 1987年 | 40篇 |
| 1986年 | 41篇 |
| 1985年 | 49篇 |
| 1984年 | 29篇 |
| 1983年 | 21篇 |
| 1982年 | 19篇 |
| 1981年 | 19篇 |
| 1980年 | 24篇 |
| 1979年 | 12篇 |
| 1978年 | 11篇 |
| 1976年 | 13篇 |
| 1975年 | 9篇 |
| 1974年 | 16篇 |
排序方式： 共有10000条查询结果，搜索用时 0 毫秒
1.
Itay Zmora Yonit Wiener-Well Evan Avraham Alpert 《The American journal of emergency medicine》2019,37(5):1006.e5-1006.e7
Background
Purulent bacterial pericarditis is a rare and potentially fatal disease. The course may be fulminant, and the presentation may pose a diagnostic challenge.Case report
An otherwise healthy 75-year-old male was brought to the emergency department in a state of general deterioration, confusion, and shock. Bedside ultrasound showed a significant pericardial effusion. His condition quickly deteriorated and the resuscitation included emergent bedside pericardiocentesis. The drainage was purulent and later cultures grew out Streptococcus pneumoniae.Why should an emergency physician be aware of this?
Purulent pericarditis is extremely rare but should be considered in the patient with a fulminant infectious process (particularly pneumonia) and signs of pericardial effusion. Treatment should include appropriate antibiotics and early drainage. 相似文献2.
3.
蒙天才 《中国继续医学教育》2020,(14):159-160
目的研究左乙拉西坦治疗小儿癫痫的疗效以及对智力的影响。方法在本院2017年4月-2019年5月收治的小儿癫痫患儿中选取74例开展研究,按照随机数表法分两组观察组和对照组,观察组37例,对照组37例,对照组采用奥卡西平进行治疗,观察组采用左乙拉西坦进行治疗,对比观察组与对照组组的治疗总有效率和智力评分变化。结果观察组与对照组比较,观察组的治疗总有效率较高,智力评分明显较高,两项对比差异有统计学意义(P <0.05)。结论左乙拉西坦治疗小儿癫痫有较好的治疗效果,治疗总有效率较高,且对患儿的智力有明显的改善作用,在实际临床小儿癫痫的治疗中具有较高的运用价值。 相似文献
4.
5.
Marta López-Fauqued Laura Campora Frédérique Delannois Mohamed El Idrissi Lidia Oostvogels Ferdinandus J. De Looze Javier Diez-Domingo Thomas C. Heineman Himal Lal Janet E. McElhaney Shelly A. McNeil Wilfred Yeo Fernanda Tavares-Da-Silva 《Vaccine》2019,37(18):2482-2493
Background
The ZOE-50 (NCT01165177) and ZOE-70 (NCT01165229) phase 3 clinical trials showed that the adjuvanted recombinant zoster vaccine (RZV) was ≥90% efficacious in preventing herpes zoster in adults. Here we present a comprehensive overview of the safety data from these studies.Methods
Adults aged ≥50 (ZOE-50) and ≥70 (ZOE-70) years were randomly vaccinated with RZV or placebo. Safety analyses were performed on the pooled total vaccinated cohort, consisting of participants receiving at least one dose of RZV or placebo. Solicited and unsolicited adverse events (AEs) were collected for 7 and 30?days after each vaccination, respectively. Serious AEs (SAEs) were collected from the first vaccination until 12?months post-last dose. Fatal AEs, vaccination-related SAEs, and potential immune-mediated diseases (pIMDs) were collected during the entire study period.Results
Safety was evaluated in 14,645 RZV and 14,660 placebo recipients. More RZV than placebo recipients reported unsolicited AEs (50.5% versus 32.0%); the difference was driven by transient injection site and solicited systemic reactions that were generally seen in the first week post-vaccination. The occurrence of overall SAEs (RZV: 10.1%; Placebo: 10.4%), fatal AEs (RZV: 4.3%; Placebo: 4.6%), and pIMDs (RZV: 1.2%; Placebo: 1.4%) was balanced between groups. The occurrence of possible exacerbations of pIMDs was rare and similar between groups. Overall, except for the expected local and systemic symptoms, the safety results were comparable between the RZV and Placebo groups irrespective of participant age, gender, or race.Conclusions
No safety concerns arose, supporting the favorable benefit-risk profile of RZV. 相似文献6.
Recognizing and managing a deteriorating patient: a randomized controlled trial investigating the effectiveness of clinical simulation in improving clinical performance in undergraduate nursing students 
下载免费PDF全文
下载免费PDF全文 7.
8.
9.
Xiaoxuan Liu Ameenat L. Solebo Livia Faes Sophie Beese Tasanee Braithwaite Matthew E. Round 《Ocular immunology and inflammation》2020,28(6):898-907
ABSTRACT
Purpose
New instrument-based techniques for anterior chamber (AC) cell counting can offer automation and objectivity above clinician assessment. This review aims to identify such instruments and its correlation with clinician estimates. 相似文献10.
目的:探究桃红四物汤联合银杏酮酯滴丸治疗老年出血性玻璃体混浊的临床疗效。方法:收集2016年12月-2018年12月我院收治的老年出血性玻璃体混浊患者67例,共67眼,根据随机对照表分为对照组和试验组,其中试验组34例,对照组33例,对照组予以银杏酮酯滴丸;试验组在对照组的基础上联用桃红四物汤。两组均服用30 d。治疗结束后对比分析两组患者临床疗效、出血吸收时间、血液流变学及视网膜中央动脉血流动力学。结果:治疗后两组患者高切全血粘度、低切全血粘度、纤维蛋白原、阻力指数(Resistance Index,RI)低于治疗前,收缩期峰值速度(Peak Systolic Velocity,PSV)、舒张末期血流速度(End Diastolic Velocity,EDV)高于治疗前,差异具有统计学意义(P<0.05);治疗后试验组临床总有效率、PSV、EDV高于对照组,出血吸收时间、高切全血粘度、低切全血粘度、纤维蛋白原、RI低于对照组,差异具有统计学意义(P<0.05)。结论:桃红四物汤联合银杏酮酯滴丸治疗老年出血性玻璃体混浊临床疗效显著,适宜临床应用推广。 相似文献